skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Time Factors remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

El-Khoueiry, Anthony B, Dr ; Sangro, Bruno, MD ; Yau, Thomas, MD ; Crocenzi, Todd S, MD ; Kudo, Masatoshi, MD ; Hsu, Chiun, MD ; Kim, Tae-You, MD ; Choo, Su-Pin, BMBS ; Trojan, Jörg, MD ; Welling, Theodore H, MD ; Meyer, Tim, MD ; Kang, Yoon-Koo, MD ; Yeo, Winnie, MD ; Chopra, Akhil, MD ; Anderson, Jeffrey, MD ; dela Cruz, Christine, MD ; Lang, Lixin, PhD ; Neely, Jaclyn, PhD ; Tang, Hao, PhD ; Dastani, Homa B, PhD ; Melero, Ignacio

The Lancet (British edition), 2017-06, Vol.389 (10088), p.2492-2502 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Material Type:
Artigo 		Adicionar ao Meu Espaço

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Mauri, Laura ; Kereiakes, Dean J ; Yeh, Robert W ; Driscoll-Shempp, Priscilla ; Cutlip, Donald E ; Steg, P. Gabriel ; Normand, Sharon-Lise T ; Braunwald, Eugene ; Wiviott, Stephen D ; Cohen, David J ; Holmes, David R ; Krucoff, Mitchell W ; Hermiller, James ; Dauerman, Harold L ; Simon, Daniel I ; Kandzari, David E ; Garratt, Kirk N ; Lee, David P ; Pow, Thomas K ; Ver Lee, Peter ; Rinaldi, Michael J ; Massaro, Joseph M

The New England journal of medicine, 2014-12, Vol.371 (23), p.2155-2166 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial

Larkin, James ; Minor, David ; D'Angelo, Sandra ; Neyns, Bart ; Smylie, Michael ; Miller, Jr, Wilson H ; Gutzmer, Ralf ; Linette, Gerald ; Chmielowski, Bartosz ; Lao, Christopher D ; Lorigan, Paul ; Grossmann, Kenneth ; Hassel, Jessica C ; Sznol, Mario ; Daud, Adil ; Sosman, Jeffrey ; Khushalani, Nikhil ; Schadendorf, Dirk ; Hoeller, Christoph ; Walker, Dana ; Kong, George ; Horak, Christine ; Weber, Jeffrey

Journal of clinical oncology, 2018-02, Vol.36 (4), p.383-390 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Kim, Youn H ; Bagot, Martine ; Pinter-Brown, Lauren ; Rook, Alain H ; Porcu, Pierluigi ; Horwitz, Steven M ; Whittaker, Sean ; Tokura, Yoshiki ; Vermeer, Maarten ; Zinzani, Pier Luigi ; Sokol, Lubomir ; Morris, Stephen ; Kim, Ellen J ; Ortiz-Romero, Pablo L ; Eradat, Herbert ; Scarisbrick, Julia ; Tsianakas, Athanasios ; Elmets, Craig ; Dalle, Stephane ; Fisher, David C ; Halwani, Ahmad ; Poligone, Brian ; Greer, John ; Fierro, Maria Teresa ; Khot, Amit ; Moskowitz, Alison J ; Musiek, Amy ; Shustov, Andrei ; Pro, Barbara ; Geskin, Larisa J ; Dwyer, Karen ; Moriya, Junji ; Leoni, Mollie ; Humphrey, Jeffrey S ; Hudgens, Stacie ; Grebennik, Dmitri O ; Tobinai, Kensei ; Duvic, Madeleine ; Abhyankar, Sunil ; Akilov, Oleg ; Alpdogan, Onder ; Beylot-Barry, Marie ; Boh, Erin ; Caballero, Dolores ; Cowan, Richard ; Dreno, Brigitte ; Dummer, Reinhard ; Fenske, Timothy ; Foss, Francine ; Fukuhara, Noriko ; Giri, Pratyush ; Habe, Koji ; Hamada, Toshihisa ; Hatake, Kiyohiko ; Iida, Shinsuke ; Ishikawa, Osamu ; Iversen, Lars ; Kiyohara, Eiji ; Koga, Hiroshi ; Korman, Neil ; Kuss, Bryone Jean ; Lamar, Zanetta ; Lansigan, Frederick ; Lechowicz, Mary Jo ; Lerner, Adam ; Magnolo, Nina ; Mark, Lawrence ; Miyagaki, Tomomitsu ; Munoz, Javier ; Nicolay, Jan Peter ; Nishiwaki, Kaoru ; Okamoto, Hiroyuki ; Ohtsuka, Mikio ; Pacheco, Theresa ; Querfeld, Christiane ; Rapini, Ronald Peter ; Sano, Shigetoshi ; Tanaka, Maiko ; Tharp, Michael D. ; Uehara, Jiro ; Wada, Hidefumi ; Wells, Jillian ; Wilcox, Ryan A. ; William, Basem ; Yonekura, Kentaro

The lancet oncology, 2018-09, Vol.19 (9), p.1192-1204 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

Moayyedi, Paul ; Eikelboom, John W. ; Bosch, Jackie ; Connolly, Stuart J. ; Dyal, Leanne ; Shestakovska, Olga ; Leong, Darryl ; Anand, Sonia S. ; Störk, Stefan ; Branch, Kelley R.H. ; Bhatt, Deepak L. ; Verhamme, Peter B. ; O’Donnell, Martin ; Maggioni, Aldo P. ; Lonn, Eva M. ; Piegas, Leopoldo S. ; Ertl, Georg ; Keltai, Matyas ; Bruns, Nancy Cook ; Muehlhofer, Eva ; Dagenais, Gilles R. ; Kim, Jae-Hyung ; Hori, Masatsugu ; Steg, P. Gabriel ; Hart, Robert G. ; Diaz, Rafael ; Alings, Marco ; Widimsky, Petr ; Avezum, Alvaro ; Probstfield, Jeffrey ; Zhu, Jun ; Liang, Yan ; Lopez-Jaramillo, Patricio ; Kakkar, Ajay K. ; Parkhomenko, Alexander N. ; Ryden, Lars ; Pogosova, Nana ; Dans, Antonio L. ; Lanas, Fernando ; Commerford, Patrick J. ; Torp-Pedersen, Christian ; Guzik, Tomek J. ; Vinereanu, Dragos ; Tonkin, Andrew M. ; Lewis, Basil S. ; Felix, Camilo ; Yusoff, Khalid ; Metsarinne, Kaj P. ; Fox, Keith A.A. ; Yusuf, Salim

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.682-691.e2 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

Cuisset, Thomas ; Deharo, Pierre ; Quilici, Jacques ; Johnson, Thomas W ; Deffarges, Stéphanie ; Bassez, Clémence ; Bonnet, Guillaume ; Fourcade, Laurent ; Mouret, Jean Philippe ; Lambert, Marc ; Verdier, Valentine ; Morange, Pierre Emmanuel ; Alessi, Marie Christine ; Bonnet, Jean Louis

European heart journal, 2017-11, Vol.38 (41), p.3070-3078 [Periódico revisado por pares]

England: Oxford University Press (OUP)

Texto completo disponível

Citações Citado por
7
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Casulo, Carla ; Byrtek, Michelle ; Dawson, Keith L ; Zhou, Xiaolei ; Farber, Charles M ; Flowers, Christopher R ; Hainsworth, John D ; Maurer, Matthew J ; Cerhan, James R ; Link, Brian K ; Zelenetz, Andrew D ; Friedberg, Jonathan W

Journal of clinical oncology, 2015-08, Vol.33 (23), p.2516-2522 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

Javle, Milind ; Lowery, Maeve ; Shroff, Rachna T ; Weiss, Karl Heinz ; Springfeld, Christoph ; Borad, Mitesh J ; Ramanathan, Ramesh K ; Goyal, Lipika ; Sadeghi, Saeed ; Macarulla, Teresa ; El-Khoueiry, Anthony ; Kelley, Robin Kate ; Borbath, Ivan ; Choo, Su Pin ; Oh, Do-Youn ; Philip, Philip A ; Chen, Li-Tzong ; Reungwetwattana, Thanyanan ; Van Cutsem, Eric ; Yeh, Kun-Huei ; Ciombor, Kristen ; Finn, Richard S ; Patel, Anuradha ; Sen, Suman ; Porter, Dale ; Isaacs, Randi ; Zhu, Andrew X ; Abou-Alfa, Ghassan K ; Bekaii-Saab, Tanios

Journal of clinical oncology, 2018-01, Vol.36 (3), p.276-282 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study

Budde, Lihua E ; Assouline, Sarit ; Sehn, Laurie H ; Schuster, Stephen J ; Yoon, Sung-Soo ; Yoon, Dok Hyun ; Matasar, Matthew J ; Bosch, Francesc ; Kim, Won Seog ; Nastoupil, Loretta J ; Flinn, Ian W ; Shadman, Mazyar ; Diefenbach, Catherine ; O'Hear, Carol ; Huang, Huang ; Kwan, Antonia ; Li, Chi-Chung ; Piccione, Emily C ; Wei, Michael C ; Yin, Shen ; Bartlett, Nancy L

Journal of clinical oncology, 2022-02, Vol.40 (5), p.481-491 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
10
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

Motzer, Robert J ; Rini, Brian I ; McDermott, David F ; Redman, Bruce G ; Kuzel, Timothy M ; Harrison, Michael R ; Vaishampayan, Ulka N ; Drabkin, Harry A ; George, Saby ; Logan, Theodore F ; Margolin, Kim A ; Plimack, Elizabeth R ; Lambert, Alexandre M ; Waxman, Ian M ; Hammers, Hans J

Journal of clinical oncology, 2015-05, Vol.33 (13), p.1430-1437 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (10.880)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (11.460)
  2. magazinearticle  (5)
  3. Web Resources  (1)
  4. Recursos Textuais  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1978  (138)
  2. 1978Até1988  (645)
  3. 1989Até1999  (1.237)
  4. 2000Até2011  (5.122)
  5. Após 2011  (4.327)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (11.353)
  2. Japonês  (1.497)
  3. Francês  (37)
  4. Português  (33)
  5. Russo  (19)
  6. Alemão  (16)
  7. Espanhol  (14)
  8. Italiano  (7)
  9. Holandês  (7)
  10. Chinês  (3)
  11. Sueco  (2)
  12. Dinamarquês  (2)
  13. Islândico  (2)
  14. Húngaro  (1)
  15. Hebraico  (1)
  16. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.